[144] Procter & Gamble Company SEC Filing

Rhea-AI Filing Summary

Form 144 notice for Procter & Gamble Company (PG) shows a proposed sale of 1,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $156,460. The filer reports acquiring 15,811 shares as a Performance Stock Program Award from Procter & Gamble and intends the sale approximately on 08/29/2025. The filing also discloses that the filer sold 6,167 shares for gross proceeds of $969,907.53. The notice includes the signed representation that the seller is unaware of undisclosed material adverse information about the issuer.

Insights

Financial Analyst

TL;DR: Routine insider sale notice; transaction sizes are small relative to issuer's outstanding shares.

The Form 144 documents a proposed sale of 1,000 shares valued at $156,460 and recent sales of 6,167 shares for $969,907.53. With total shares outstanding stated as 2,342,371,488, these transactions represent a de minimis fraction of the company equity and do not, by themselves, imply material change to ownership or control. The acquisition date and nature (performance stock award) are disclosed, which is typical for equity compensation-driven sales. Impact on market or governance is likely negligible based on disclosed sizes.

Corporate Governance Expert

TL;DR: Filing meets Rule 144 procedural requirements; includes standard certification about material nonpublic information.

The notice contains required elements: broker identity, share amounts, acquisition method (performance award), dates of acquisition and intended sale, and prior sales within three months. The signer affirms no undisclosed material adverse information and references trading-plan considerations consistent with Rule 10b5-1 language. From a governance perspective, disclosures are complete as presented; there is no indication of unusual timing or size that would raise compliance concerns based on the disclosed facts alone.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 38th Floor New York NY 10004	1000	156460.00	2342371488	08/29/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	08/18/2025	Performance Stock Program Award	The Procter & Gamble Company			15811	08/18/2025	NA

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Susan Street Whaley One Procter & Gamble Plaza Cincinnati OH 45202	Common Stock	08/19/2025	6167	969907.53

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Procter & Gamble's (PG) Form 144 filed here report?

The filing reports a proposed sale of 1,000 shares of PG common stock valued at $156,460, to be sold via Morgan Stanley Smith Barney around 08/29/2025.

Who acquired the shares being sold and how were they acquired?

The shares were acquired by the filer on 08/18/2025 under a Performance Stock Program Award from The Procter & Gamble Company; the filer acquired 15,811 shares on that date.

Has the filer sold any PG shares recently?

Yes. The filer sold 6,167 shares on 08/19/2025 for gross proceeds of $969,907.53 as disclosed in the filing.

Which broker is handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services, 1 New York Plaza, 38th Floor, New York, NY 10004.

Does the filing state the number of shares outstanding for PG?

Yes. The filing shows 2,342,371,488 shares outstanding.